Literature DB >> 31725007

Preventing a nonexistent entity: the curious case of contrast and acute kidney injury.

Swapnil Hiremath1, Juan Carlos Q Velez.   

Abstract

PURPOSE OF REVIEW: In recent years, doubt has been cast on the existence of contrast-induced acute kidney injury. The skepticism has stemmed from observational studies from large administrative healthcare databases. Although they correctly call that contrast-induced acute kidney injury is less common than previously thought, they cannot completely exclude selection bias. RECENT
FINDINGS: Though less common than previously thought, contrast-induced acute kidney injury still exists. The only prophylactic method that remains valid is that of isotonic volume expansion, which is still deemed beneficial in high-risk patients. N-acetylcysteine and sodium bicarbonate are ineffective and their use should be abandoned.
SUMMARY: Contrast-induced kidney injury should be defined based on clinical grounds, not merely on biochemical numbers. More research to validate a clinical definition is necessary in order to accurately re-examine its incidence.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31725007     DOI: 10.1097/MNH.0000000000000562

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  2 in total

1.  Canadian Association of Radiologists Guidance on Contrast-Associated Acute Kidney Injury.

Authors:  D Blair Macdonald; Casey D Hurrell; Andreu F Costa; Matthew D F McInnes; Martin O'Malley; Brendan J Barrett; Pierre Antoine Brown; Edward G Clark; Anastasia Hadjivassiliou; Iain Donald Craik Kirkpatrick; Jeremy Rempel; Paul Jeon; Swapnil Hiremath
Journal:  Can J Kidney Health Dis       Date:  2022-05-24

2.  Comparison of Pre-Amputation Evaluation in Patients with and without Chronic Kidney Disease.

Authors:  Nivetha Subramanian; Jialin Han; Nicholas J Leeper; Elsie G Ross; Maria E Montez-Rath; Tara I Chang
Journal:  Am J Nephrol       Date:  2021-05-06       Impact factor: 4.605

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.